Accra: The Food and Drugs Authority (FDA) has issued a public warning urging individuals to avoid using Omama Herbal Mixture, an anti-malaria medicine.
According to Ghana News Agency, the FDA's statement revealed that the herbal medicine contains chemicals that could pose risks if used without medical supervision. The warning follows a collaborative laboratory analysis and market surveillance conducted with the Ghana Police Service.
The analysis found that Omama Herbal Mixture is adulterated with allopathic medicines such as Diazepam, Metronidazole, Paracetamol, and Niacinamide. These substances are not expected in a product registered as a herbal medicine for malaria and appetite loss. The FDA emphasized the potential dangers of consuming these compounds without health professional guidance.
The authority has also stated its intention to collaborate with Omama Herbal Group Limited to recall the product from the market. This action will ensure safe disposal and may lead to regulatory measures, including possible criminal prosecution.
The FDA reassured the public of its commitment to safeguarding public health and urged citizens to report any sales of Omama Herbal Mixture to nearby FDA offices. Additionally, the FDA recently suspended the operations of nine sachet water producers in the Western North Region due to expired registration licenses. This move was part of efforts to ensure compliance with manufacturing and safety standards in Wiawso Municipality and Bia West and East districts, as explained by Mr. Albert Ankamah, Western North Regional Director of the FDA.